FDA Drug Application (022271) for NESINA by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number022271
Product Number001
FormTABLET;ORAL
DosageEQ 6.25MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNESINA
Active IngredientALOGLIPTIN BENZOATE

Active IngredientCount
List of drugs with Active Ingredient ALOGLIPTIN BENZOATE3


Back to FDA Applications sponsored by TAKEDA PHARMS USA